Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 41

Trial Status

Terminated2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT01964755Phase 2Terminated
Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma
Epstein Barr Virus Associated Hodgkin's LymphomaEpstein Barr Virus Associated Non Hodgkin's LymphomaPost-Transplant Lymphoproliferative Disease
StudychairStart date: 2009-04-21

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01964755Phase 2StudyChair

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

Epstein Barr Virus Associated Hodgkin's LymphomaEpstein Barr Virus Associated Non Hodgkin's LymphomaPost-Transplant Lymphoproliferative Disease
Terminated
NCT00854581Phase 4PrincipalInvestigator

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

LymphomaPrecancerous/Nonmalignant Condition
Terminated

All 2 trials loaded